Related Experiment Video
Updated: Jun 3, 2026
Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model
Published on: September 27, 2024
Could nanoparticle systems have a role in the treatment of cerebral gliomas?
Gerardo Caruso1, Mariella Caffo, Concetta Alafaci
1Department of Neurosciences, Psychiatry and Anaesthesiology, Neurosurgical Clinic, University of Messina School of Medicine, Messina, Italy. gcaruso@unime.it
Abstract:
Malignant brain tumors are difficult to manage clinically and are associated with high rates of morbidity and mortality. Late diagnosis and the limitations of conventional therapies that may result from inefficient delivery of the therapeutic or contrast agent to brain tumors due to the blood-brain barrier and nonspecificity of the agents, are major reasons for this unsolved clinical problem. Nanotechnology involves the design, synthesis, and characterization of materials and devices that have a functional organization in at least one dimension on the nanometer scale. The nanoparticle has emerged as a potential vector for brain delivery, able to overcome the difficulties of modern strategies. Moreover, multifunctionality can be engineered into a single nanoplatform so that it can provide tumor-specific detection, treatment, and follow-up monitoring. This review reports the latest research in nanoparticle-based glioma treatment.
From The Clinical Editor:
In recent years, nanoparticles have emerged as potential delivery vectors targeting brain tumors, including multifunctional NP-s allowing tumor-specific detection, treatment, and follow-up monitoring. This review summarizes the latest research in nanoparticle-based glioma treatment.
Insights
Nanotechnology offers new hope for treating malignant brain tumors. Nanoparticles can overcome the blood-brain barrier for targeted delivery, improving detection and treatment of gliomas.
Area of Science:
- Nanotechnology and materials science applied to medicine.
- Biomedical engineering and drug delivery systems.
- Oncology and neurosurgery research.
Background:
- Malignant brain tumors present significant clinical management challenges.
- Inefficient drug delivery across the blood-brain barrier limits conventional therapies.
- Nanoparticles offer a promising solution for targeted brain tumor treatment.
Purpose of the Study:
- To review the latest advancements in nanoparticle-based glioma treatment.
- To highlight the potential of nanotechnology in overcoming delivery challenges.
- To discuss multifunctional nanoplatforms for diagnosis and therapy.
Main Methods:
- Literature review of recent research in nanoparticle-based glioma therapy.
- Analysis of nanotechnology applications for drug and contrast agent delivery.
- Examination of engineered nanoplatforms for tumor detection and monitoring.
Main Results:
- Nanoparticles demonstrate potential as effective vectors for brain tumor delivery.
- Multifunctional nanoplatforms enable tumor-specific detection and treatment.
- Engineered nanoparticles can overcome the limitations of conventional therapies.
Conclusions:
- Nanotechnology provides a promising strategy for improving glioma management.
- Nanoparticle-based approaches offer enhanced targeting and therapeutic efficacy.
- Further research in this area holds potential for better patient outcomes.
